View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
October 27, 2011

OrbusNeich Genous stent proven effective in study

Twelve-month follow-up data from a clinical trial of OrbusNeich's Genous stent has revealed that the device is safe and effective.

Twelve-month follow-up data from a clinical trial of OrbusNeich’s Genous stent has revealed that the device is safe and effective.

The Genous stent is an endothelial progenitor cell capture technology that enhances the natural healing of the vessel wall.

The multi-centre prospective clinical study, called e-HEALING, included 4,939 patients with at least one lesion suitable for non-urgent percutaneous coronary intervention.

Target vessel failure occurred in 11.7% of patients over the age of 75, in 8.8% of patients between the ages of 65 and 74, and in 7% of patients younger than 65.

Secondary endpoint includes composite of cardiac death, myocardial infarction and the target lesion revascularization rate.

 

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management